Osaka, Japan

Taizo Ono


Average Co-Inventor Count = 5.7

ph-index = 9

Forward Citations = 228(Granted Patents)


Location History:

  • Tokyo, JP (1986)
  • Osaka, JP (1983 - 1987)
  • San Gabriel, CA (US) (1986 - 1988)
  • Kyoto, JP (1987 - 1990)

Company Filing History:


Years Active: 1983-1990

Loading Chart...
24 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Taizo Ono in Pharmaceutical Patents

Introduction: Taizo Ono is an accomplished inventor based in Osaka, Japan, recognized for his significant contributions to the field of pharmaceutical innovations. With an impressive portfolio of 24 patents, Ono has played a pivotal role in the development of novel compounds with therapeutic applications, particularly in the realm of cardiovascular health.

Latest Patents: Among Taizo Ono's recent patents are several focused on dihydropyridine derivatives, which are represented by a specific chemical formula involving various alkyl and aromatic groups. These compounds are known for their remarkable calcium blocking action and antihypertensive properties. They serve as potential therapeutic agents for conditions such as hypertension and thrombosis. His formulations also emphasize the effectiveness of these derivatives in pharmaceutical compositions and their varied medicinal uses.

Career Highlights: Taizo Ono's career at The Green Cross Corporation underscores his dedication to pharmaceutical innovation. His work has not only contributed to a better understanding of dihydropyridine derivatives but also has laid groundwork for effective treatments in cardiology. His drive to create effective medications highlights the importance of research and patenting in the pharmaceutical industry.

Collaborations: Throughout his career, Ono has collaborated with esteemed colleagues such as Kazumasa Yokoyama and Chikara Fukaya. These collaborations have fostered an environment of shared knowledge and expertise, enhancing the innovation process and leading to the successful development of numerous impactful patents.

Conclusion: Taizo Ono's contributions to the field of pharmaceuticals, particularly through his work on dihydropyridine derivatives, continue to make significant impacts on medical treatments and patient care. His dedication to innovation within The Green Cross Corporation exemplifies the critical link between invention and practical application in the health sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…